SunandanaChandraMDMS

Oncology • Chicago, IL

Hematologic Oncology, Melanoma

Physician

Join to view full profile

Dr. Chandra is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Chandra's full profile

Already have an account?

Office
675 N Saint Clair St
Chicago, IL 60611
Phone+1 312-695-5378

Fax+1 312-695-0188
Is this information wrong?

Education & Training

NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2011 - 2014
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2008 - 2011
Michigan State University College of Human MedicineClass of 2008

Certifications & Licensure

IL State Medical License 2014 - 2026
NY State Medical License 2011 - 2016
OH State Medical License 2008 - 2011
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma Start of enrollment: 2015 Nov 23
Recruiting
Phase 2, Phase 3
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer Start of enrollment: 2019 May 17
Active, not recruiting
Phase 2
Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma Start of enrollment: 2021 Jul 08
Active, not recruiting
Phase 2

Publications & Presentations

PubMed

1 citations
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers.
Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason J Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwa...> ;Journal of Clinical Oncology. 2024 Mar 20
Anatomic Subtype Differences in Extramammary Paget Disease: A Meta-Analysis.
Nour Kibbi, Joshua L Owen, Brandon Worley, Jake X Wang, Vishnu Harikumar, Sumaira Z Aasi, Sunandana Chandra, Jennifer N Choi, Yasuhiro Fujisawa, Christos Iavazzo, John...> ;JAMA Dermatology. 2024 Apr 1
122 citations
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
Sapna P Patel, Megan Othus, Yuanbin Chen, G Paul Wright Jr, Kathleen J Yost, John R Hyngstrom, Siwen Hu-Lieskovan, Christopher D Lao, Leslie A Fecher, Thach-Giao Truon...> ;The New England Journal of Medicine. 2023 Mar 2
Reply to O. Devlin et al.
Sunandana Chandra, Jacob S Choi, Jeffrey A Sosman> ;Journal of Clinical Oncology. 2023 Apr 20
106 citations
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.
Atkins, M., Lee, S., Chmielowski, B., Tarhini, A., Cohen, G., Truong, T., Moon, H., Davar, D., O'Rourke, M., Stephenson, J., Curti, B., Urba, W., Brell, J., Funchain, ...> ;Journal of Clinical Oncology. 2023 Jan 10
7 citations
Endocrine side effects of immune checkpoint inhibitors.
Zulma Cardona, Jeffrey A Sosman, Sunandana Chandra, Wenyu Huang> ;Frontiers in Endocrinology. 2023 Jan 1
2 citations
Targeted Therapy for Melanomas Without BRAF V600 Mutation.
Jacob S Choi, Sunandana Chandra> ;Current Oncology Reports. 2022 Dec 1
4 citations
Melanoma: Does Sequencing Really Matter?
Sunandana Chandra, Jacob S Choi, Jeffrey A Sosman> ;Journal of Clinical Oncology. 2023 Jan 10
7 citations
Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery.
Jessica G Labadie, Sarah A Ibrahim, Brandon Worley, Bianca Y Kang, Uros Rakita, Sarah Rigali, Kenneth A Arndt, Eric Bernstein, Jeremy A Brauer, Sunandana Chandra, Aash...> ;JAMA Dermatology. 2022 Oct 1
10 citations
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer.
Ann W Silk, Christopher A Barker, Shailender Bhatia, Kathryn B Bollin, Sunandana Chandra, Zeynep Eroglu, Brian R Gastman, Kari L Kendra, Harriet Kluger, Evan J Lipson,...> ;Journal for Immunotherapy of Cancer. 2022 Jul 1
8 citations
Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience.
Lorenzo Gerratana, Michael Movarek, Firas Wehbe, Neelima Katam, Devalingam Mahalingam, Jeannine Donahue, Ami Shah, Young K Chae, Mary Mulcahy, Dean Tsarwhas, Victoria ...> ;JCO Precision Oncology. 2022 Jun 1
4 citations
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.
Gino Kim In, Aparna Nallagangula, Jacob Seung Choi, Lisa Tachiki, Matthew J Blackburn, Stephen Capone, Kathryn B Bollin, Daniel Y Reuben, Keisuke Shirai, Sandy Zhang-N...> ;Journal for Immunotherapy of Cancer. 2022 May 1
33 citations
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease.
Nour Kibbi, Joshua L Owen, Brandon Worley, Jake X Wang, Vishnu Harikumar, Malia B Downing, Sumaira Z Aasi, Phyu P Aung, Christopher A Barker, Diana Bolotin, Jeremy S B...> ;JAMA Oncology. 2022 Apr 1
24 citations
BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma.
Janice M Mehnert, Tara C Mitchell, Alexander C Huang, Tomas S Aleman, Benjamin J Kim, Lynn M Schuchter, Gerald P Linette, Giorgos C Karakousis, Sheryl Mitnick, Lydia G...> ;Clinical Cancer Research. 2022 Mar 15
10 citations
Leptomeningeal metastases: the future is now.
Rimas V Lukas, Jigisha P Thakkar, Massimo Cristofanilli, Sunandana Chandra, Jeffrey A Sosman, Jyoti D Patel, Priya Kumthekar, Roger Stupp, Maciej S Lesniak> ;Journal of Neuro-Oncology. 2022 Feb 1
25 citations
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
Briana R. Halle, Allison Betof Warner, Farzana Y Zaman, Andrew Haydon, Prachi Bhave, Anna K. Dewan, Fei Ye, Rebecca Irlmeier, Paras Mehta, Nicholas Kurtansky, Mario E....> ;Journal for Immunotherapy of Cancer. 2021 Oct 1
Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma.
Antoni Ribas, Alain Algazi, Paolo A. Ascierto, Marcus O. Butler, Sunandana Chandra, Michael D. Gordon, Leonel Hernandez-Aya, Donald P. Lawrence, Jose Lutzky, Wilson H....> ;Nature Communications. 2021 Aug 12
14 citations
Harnessing natural killer cells in cancer immunotherapy: A review of mechanisms and novel therapies
Frederique St-Pierre, Shailender Bhatia, Sunandana Chandra> ;Cancers. 2021 Apr 20
38 citations
The State of Melanoma: Emergent Challenges and Opportunities.
Michael B. Atkins, Clara Curiel-Lewandrowski, David E. Fisher, Susan M. Swetter, Hensin Tsao, Julio A. Aguirre-Ghiso, Maria S. Soengas, Ashani T. Weeraratna, Keith T. ...> ;Clinical Cancer Research. 2021 Jan 7
43 citations
PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma.
Antoni Ribas, Alain Algazi, Paolo A. Ascierto, Marcus O. Butler, Sunandana Chandra, Michael D. Gordon, Leonel Hernandez-Aya, Donald P. Lawrence, Jose Lutzky, Wilson H....> ;Nature Communications. 2020 Dec 7
3 citations
Real-world outcomes among US Merkel cell carcinoma patients initiating immune checkpoint inhibitors or chemotherapy.
Sunandana Chandra, Ying Zheng, Shivani Pandya, Ting Yu, Mairead Kearney, Li Wang, Ruth Kim, Hemant Phatak> ;Future Oncology. 2020 Sep 4
24 citations
A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma
Merve Hasanov, Matthew J. Rioth, Kari Kendra, Leonel Hernandez-Aya, Richard W. Joseph, Stephen K. Williamson, Sunandana Chandra, Keisuke Shirai, Christopher D. Turner,...> ;Cancers. 2020 Aug 13
24 citations
CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma
Michael R. Migden, Sunandana Chandra, Guilherme Rabinowits, Chieh I. Chen, Jigar Desai, Alex Seluzhytsky, Medha Sasane, Benedetta Campanelli, Zhen Chen, Morganna Freem...> ;Future Oncology. 2020 Jan 1
14 citations
Sebaceous carcinoma: controversies and their evidence for clinical practice.
Nour Kibbi, Brandon Worley, Joshua L. Owen, Ryan C. Kelm, Christopher K. Bichakjian, Sunandana Chandra, Hakan Demirci, John Y.S. Kim, Kishwer S. Nehal, J. Regan Thomas...> ;Archives of Dermatological Research. 2020 Jan 1
78 citations
Sebaceous carcinoma: evidence-based clinical practice guidelines
Joshua L. Owen, Nour Kibbi, Brandon Worley, Ryan C. Kelm, Jordan V Wang, Christopher A. Barker, Ramona Behshad, Christopher K. Bichakjian, Diana Bolotin, Jeremy S. Bor...> ;The Lancet. Oncology. 2019 Dec 1
Join now to see all

Press Mentions

The Importance of Having Difficult Conversations with PatientsDecember 2nd, 2022
mRNA Vaccines Get Ready for Their Next Act: Fighting CancerSeptember 21st, 2021
Exicure Provides Interim Results from Ongoing Phase 1b/2 Clinical Trial of Cavrotolimod (AST-008)August 5th, 2021
Join now to see all